SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla informs about company updates

16 Mar 2016 Evaluate

With reference to the earlier intimation dated May 12, 2014, Cipla has now informed that Cipla (EU), UK (‘Cipla UK’), a wholly owned subsidiary of the Company, has pursuant to the approval of the board of Cipla UK, made an additional investment of USD 3 million in Chase Pharmaceuticals Corporation Inc., US (‘Chase’) towards full settlement of its obligation under the agreed arrangement for investment in Chase. Consequently, Cipla UK’s total investment in Chase would aggregate to approximately USD 5.12 million for a 16.7% stake on a fully diluted basis.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1294.95 -10.90 (-0.83%)
24-Apr-2026 15:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.00
Dr. Reddys Lab 1316.35
Cipla 1294.95
Zydus Lifesciences 927.80
Lupin 2296.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×